Overview

A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate in patients that oral rabeprazole produces equivalent acid suppression to intravenous pantoprazole on Day 1 of drug administration.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen-Ortho Inc., Canada
Treatments:
Pantoprazole
Rabeprazole